Renaissance BioScience secures financing

Renaissance BioScience Corp. has closed a new round of private financing.

Renaissance BioScience raised $Subscriber ONLY content: read our research and get insight on this and other deals. We offer monthly or yearly recurring or one-time trial subscriptions. Subscribe today and see what you have been missing!

Vancouver based Renaissance BioScience Corp. develops proprietary yeast-based technology solutions for food and beverage manufacturers worldwide. Its products include commercially available yeast strains that prevent the formation of two separate and significant naturally occurring contaminants: acrylamide in carbohydrate-rich foods and coffee, and hydrogen sulfide in wine, beer and cider.

photo credit: Renaissance BioScience


Ted Liu
Ted Liu, M.Sc. (Mining), MBA (Finance), is the Editor of Private Capital Journal, TechnologyMetals.ca, GoldSilverMetals.ca, and former Editor of Canadian Private Equity. Ted has been passionately tracking Canadian private capital industry since 1992, most recently served as Research Director for The Canadian Venture Capital and Private Equity Association (CVCA). Ted was the architect of CVCA infobase, and is the architect of sophisticated and advanced CPE Media Private Capital Dealbase. Ted is President of CPE Media Inc., Canada's independent, trusted and unbiased data provider tracking Canadian VC/PE, private capital industry and public market.
Top